AAV Ablates Neurogenesis in the Adult Murine Hippocampus

Autor: Fred H. Gage, Christina K. Lim, Stacy Kim, Iryna Gallina, Ondrej Novak, Alexander Newberry, Cooper W Bloyd, Nolan Mac, Christian D Saavedra, J. Tiago Gonçalves, Matthew Shtrahman, Sarah L. Parylak, Stephen T. Johnston
Rok vydání: 2020
Předmět:
Central Nervous System
Male
0301 basic medicine
Mouse
hippocampus
viruses
Genetic enhancement
Inbred C57BL
neuroscience
Mice
Transduction (genetics)
0302 clinical medicine
Neural Stem Cells
dentate gyrus
Biology (General)
Neurons
0303 health sciences
Cell Death
General Neuroscience
Neurogenesis
Gene Therapy
General Medicine
Dependovirus
Stem Cells and Regenerative Medicine
gene therapy
Neural stem cell
3. Good health
Cell biology
adult neurogenesis
Medicine
Stem Cell Research - Nonembryonic - Non-Human
Development of treatments and therapeutic interventions
Stem cell
Immediate early gene
Research Article
Biotechnology
Adult
Cell type
QH301-705.5
Science
Genetic Vectors
regenerative medicine
adeno-associated virus (AAV)
adeno-associated virus
Biology
General Biochemistry
Genetics and Molecular Biology

Viral vector
03 medical and health sciences
stem cells
Genetics
Animals
Humans
neural progenitor cell
mouse
Cell Proliferation
030304 developmental biology
Inflammation
5.2 Cellular and gene therapies
General Immunology and Microbiology
Dentate gyrus
Neurosciences
Genetic Therapy
Stem Cell Research
Mice
Inbred C57BL

030104 developmental biology
Biochemistry and Cell Biology
030217 neurology & neurosurgery
Neuroscience
Zdroj: eLife
eLife, Vol 10 (2021)
DOI: 10.1101/2020.01.18.911362
Popis: Recombinant adeno-associated virus (rAAV) has been widely used as a viral vector across mammalian biology and has been shown to be safe and effective in human gene therapy. We demonstrate that neural progenitor cells (NPCs) and immature dentate granule cells (DGCs) within the adult murine hippocampus are particularly sensitive to rAAV-induced cell death. Cell loss is dose dependent and nearly complete at experimentally relevant viral titers. rAAV-induced cell death is rapid and persistent, with loss of BrdU-labeled cells within 18 hours post-injection and no evidence of recovery of adult neurogenesis at 3 months post-injection. The remaining mature DGCs appear hyperactive 4 weeks post-injection based on immediate early gene expression, consistent with previous studies investigating the effects of attenuating adult neurogenesis. In vitro application of AAV or electroporation of AAV2 inverted terminal repeats (ITRs) is sufficient to induce cell death. Efficient transduction of the dentate gyrus (DG)—without ablating adult neurogenesis—can be achieved by injection of rAAV2-retro serotyped virus into CA3. rAAV2-retro results in efficient retrograde labeling of mature DGCs and permits in vivo 2-photon calcium imaging of dentate activity while leaving adult neurogenesis intact. These findings expand on recent reports implicating rAAV-linked toxicity in stem cells and other cell types and suggest that future work using rAAV as an experimental tool in the DG and as a gene therapy for diseases of the central nervous system (CNS) should be carefully evaluated.
Databáze: OpenAIRE